Sri Parshva Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 40.00 Cr
as on 23-12-2024
- Satisfied Charges ₹ 35.00 Cr
as on 23-12-2024
- Revenue 639.93%
(FY 2023)
- Profit 480.88%
(FY 2023)
- Ebitda 771.52%
(FY 2023)
- Net Worth 535.62%
(FY 2023)
- Total Assets 12.61%
(FY 2023)
About Sri Parshva Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹40.00 Cr. The company has closed loans amounting to ₹35.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sambit Mohanty, Omprakash Bhandari, and Venkata Bachotti serve as directors at the Company.
- CIN/LLPIN
U85300KA2021PTC154908
- Company No.
154908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2021
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sri Parshva Pharma Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sambit Mohanty  | Director | 11-Nov-2022 | Current |
| Omprakash Bhandari | Whole-Time Director | 26-Nov-2021 | Current |
| Venkata Bachotti | Director | 07-Mar-2024 | Current |
Financial Performance of Sri Parshva Pharma Distributors.
Sri Parshva Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 639.93% increase. The company also saw a substantial improvement in profitability, with a 480.88% increase in profit. The company's net worth Soared by an impressive increase of 535.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Parshva Pharma Distributors?
In 2023, Sri Parshva Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Novacare Healthcare Solutions Private LimitedActive 6 years 7 monthsSambit Mohanty is a mutual person
- Dhanvanthri Super Speciality Private LimitedActive 1 year 5 months
Sambit Mohanty is a mutual person
- Sri Rama Pharmaceutical Distributors Private LimitedActive 3 years 2 months
Sambit Mohanty and Venkata Bachotti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Apr 2023 | ₹40.00 Cr | Open |
Others Creation Date: 11 Mar 2022 | ₹35.00 Cr | Satisfied |
How Many Employees Work at Sri Parshva Pharma Distributors?
Sri Parshva Pharma Distributors has a workforce of 108 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Parshva Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Parshva Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
